Estocang Biopharmaceutical (Tianjin) Co., Ltd. was established in August 2020. It is a new drug research and development enterprise based in China and facing the world. It is committed to the development of innovative drugs in the fields of oncology, metabolism, and other life-threatening diseases.

Tags

Neoplasms

Immune System Diseases

Other Diseases

Small molecule drug

Proteolysis-targeting chimeras (PROTAC)

CAR-T

Disease domain score

A glimpse into the focused therapeutic areas

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Disease Domain	Count

Neoplasms	4
Immune System Diseases	4
Nervous System Diseases	2
Hemic and Lymphatic Diseases	2
Endocrinology and Metabolic Disease	1

Top 5 Drug Type	Count

Small molecule drug	2
Unknown	2
CAR-T	2
Proteolysis-targeting chimeras (PROTAC)	1

Top 5 Target	Count

OX2R(Orexin receptor type 2)	1
Orexin receptor x orexin	1
EZH2(Histone-lysine N-methyltransferase EZH2)	1
KRAS(GTPase KRas)	1
MLL1(lysine methyltransferase 2A)	1

Corporation Tree

Boost your research with our corporation tree data.

view full example data

Pipeline

Pipeline Snapshot as of 27 Jun 2026

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Discovery

Preclinical

Phase 1

Other

Current Projects

Drug(Targets)	Indications	Global Highest Phase

AXT-1003 ( EZH2 )	Peripheral T-Cell Lymphoma More	Phase 1
AXT-1007 ( OX2R )	Depressive Disorder More	Preclinical
AXT-2008	Autoimmune Diseases More	Preclinical
AXT-1004 ( MLL1 )	Solid tumor More	Preclinical
AXT-2003	Autoimmune Diseases More	Preclinical

Deal

Boost your decision using our deal data.

view full example data

Translational Medicine

Boost your research with our translational medicine data.

view full example data

Profit

Explore the financial positions of over 360K organizations with Synapse.

view full example data

Grant & Funding(NIH)

Access more than 2 million grant and funding information to elevate your research journey.

view full example data

Investment

Gain insights on the latest company investments from start-ups to established corporations.

view full example data

Financing

Unearth financing trends to validate and advance investment opportunities.

view full example data

AI Agents Built for Biopharma Breakthroughs

Accelerate discovery. Empower decisions. Transform outcomes.

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.

Bio

Bio Sequences Search & Analysis

Chemical

Chemical Structures Search & Analysis